Maravai Lifesciences Holdings (MRVI) Asset Writedowns and Impairment (2025 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly Asset Writedowns and Impairment came in at $605000.0 in Q1 2026, down 95.13% year-on-year from $12.4 million in Q1 2025, and down 87.65% quarter-over-quarter from $4.9 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Asset Writedowns and Impairment (2025 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $605000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Maravai Lifesciences Holdings | 983.98 Mn | 818.06 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 605,000.00 |
| Mar 31, 2026 | 605,000.00 |
| Dec 31, 2025 | 4.90 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Mar 31, 2025 | 12.44 Mn |